Company Overview and News

8
CANADA STOCKS-Precious metal shares drive Canada's main stock index higher

3h reuters
Oct 15 (Reuters) - Canada’s main stock index was higher on Monday as mining stocks rose on the back of climbing gold prices.
ACB RNX RNX.WT RNKLF ACBFF EDVVF EDVMF EVR IAG BBRY EDV

10
Telecom Stock Roundup: Verizon Powers Body Camera, AT&T's Insurance Venture & More

2018-10-11 zacks - 1
In the past five trading days, telecom stocks initially witnessed an uptrend and followed a relatively flat trajectory thereafter, only to decline in the later stages due to macroeconomic concerns. As the earnings season gains steam, equity markets appear a bit shaky with high volatility and lower-than-expected performance from the technology sector, of which telecom is part. The benchmark S&P 500 Index continued its downtrend throughout the past week, the longest streak since Donald Trump’s election, with the technology sector taking the hardest hit.
MSI VSAT CNA VZ QCOM BB BB SBAC AAXN BBRY VZA

3
TIM Participacoes (TSU) Surges: Stock Moves 5.8% Higher

2018-10-09 zacks
TIM Participacoes S.A. (TSU - Free Report) was a big mover last session, as the company saw its shares rise nearly 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company—as the stock is now up 11.5% in the past one-month time frame. The company has seen no changes when it comes to estimate revision over the past few weeks, while the Zacks Consensus Estimate for the current quarter has also remained unchanged.
BB BB BBRY

37
BlackBerry (BB) Extends Services Portfolio to Drive Revenues

2018-10-05 zacks
BlackBerry Limited (BB - Free Report) recently announced that it is adding a quantum-resistant code signing server to its range of cryptography tools. To be offered from November 2018, the solution will allow software to be digitally signed using a scheme that will be tough to break with a quantum computer. Notably, BlackBerry’s quantum-resistant code signing server uses cryptographic libraries from ISARA Corporation — a leader in agile quantum-safe security solutions.
HD ORAN S GJH UZA BB BB USM UZC BBRY UZB

26
Cyber security stocks fall as investors shrug off China spy threat

2018-10-04 marketwatch
Shares of cyber security companies were mostly lower Thursday, along with the broader stock market, as investors shrugged off a report that Chinese operatives inserted microchips in motherboards sold to Apple Inc. AAPL, -1.65% and Amazon.com Inc. AMZN, -2.04% The ETFMG Prime Cyber Security ETF HACK, -1.00% shed 0.9% in morning trade, with 43 of its 52 equity components losing ground, while the First Trust Nasdaq Cybersecurity ETF CIBR, -1.
SYMC FEYE SAIL OKTA ZS AAPL PANW BBRY

10
Telecom Stock Roundup: Harris to Power F-35, BlackBerry Kicks Off Sector Earnings

2018-10-04 zacks
In the past five trading days, telecom stocks initially rallied on optimism over improving economic fundamentals, as traders eventually shrugged off concerns regarding the burgeoning trade war. It seemed as if the equity markets have already factored in the repercussions from the prevailing tariff war between the United States and China, and showed resilience in the face of adversity. However, the stocks followed a flat trajectory, thereafter, and declined slightly at the end of the week on concerns regarding the fallout of the net neutrality law passed by California.
MSI CSBR AAPL HRS QCOM BB BB SBAC BBRY

3
BlackBerry (BB) in Focus: Stock Moves 11.7% Higher

2018-10-01 zacks
BlackBerry Limited (BB - Free Report) was a big mover last session, as the company saw its shares rise nearly 12% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $9.85 to $10.64 in the past one-month time frame.
2454 BB BB BBRY

3
BlackBerry (BB) Surpasses Q2 Earnings and Revenue Estimates

2018-10-01 zacks
BlackBerry Limited (BB - Free Report) reported healthy financial results for second-quarter fiscal 2019 (ended Aug 31, 2018), driven by growth in BlackBerry Technology Solutions and Enterprise Software and Services businesses. Net Income On a GAAP basis, net income for the reported quarter came in at $43 million compared with $19 million in the year-ago quarter. The year-over-year rise was primarily due to lower operating expenses.
ORAN CMTL UBNT FSLR BB BB RPM BBRY

5
BBRY / BlackBerry Ltd. 6-K (Current Report of Foreign Issuer)

2018-09-28 sec.gov - 2
Document UNITED STATES
BBRY

8
CANADA STOCKS - TSX falls 0.81 percent

2018-09-28 reuters - 1
NEW YORK, Sept 28 (Reuters) - * The Toronto Stock Exchange’s S&P/TSX fell 131.48 points, or 0.81 percent, to 16,073.14. * Leading the index were BlackBerry Ltd, up 10.2 percent, Paramount Resources Ltd, up 7.6 percent, and Aurora Cannabis Inc, higher by 6.3 percent. * Lagging shares were West Fraser Timber Co Ltd, down 6.4 percent, Norbord Inc, down 4.9 percent, and First Quantum Minerals Ltd, lower by 4.
TRQ ACB ACBFF FQVLF NBRXF TRQ FQM POU OSB BBRY PRMRF

6
BlackBerry Limited (BB) CEO John Chen on Q2 2019 Results - Earnings Call Transcript

2018-09-28 seekingalpha - 3
Good morning and welcome to the BlackBerry Fiscal Year 2019 Second Quarter Results Conference Call. My name is Lisa and I will be your conference moderator for today's call. During the presentation, all participants will be in a listen-only mode. We will be facilitating a brief question-and-answer session towards the end of the conference. [Operator Instructions] As a reminder, this conference is being recorded for replay purposes.
BB BB BBRY

12
BlackBerry profit beats on autonomous tech demand, shares jump

2018-09-28 channelnewsasia - 1
Canadian software maker BlackBerry Ltd's second-quarter profit more than doubled, helped by higher billings at its software and services business and lower costs.
AAPL QCOM BIDU BBRY

3
BlackBerry shares soar after it reports financial results that exceeded expectations

2018-09-28 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
BBRY

3
How BlackBerry Offered Up a Big Q2 Beat

2018-09-28 247wallst
BlackBerry Ltd. (NYSE: BB) reported its fiscal second-quarter financial results before the markets opened on Friday. The company said that it had $0.04 in earnings per share (EPS) and $210 in revenue, compared with consensus estimates that called for $0.01 in EPS and revenue of $207.71 million. The same period of last year reportedly had EPS of $0.05 and $249 million in revenue.
BB BBRY

3
BlackBerry's stock jumps after profit and revenue beat expectations

2018-09-28 marketwatch
Shares of BlackBerry Ltd. BB, +14.43% rallied 3% in premarket trade Friday, after the business software company reported fiscal second-quarter earnings and revenue that beat expectations. For the quarter to Aug. 31, the company reported net income was $43 million, but a loss per diluted share of 4 cents, compared with net income of $19 million, but a loss per diluted share of 8 cents, in the same period a year ago.
BBRY

BBRY : BlackBerry Ltd Stock Analysis and Research Report

2017-10-26 - Asif

BlackBerry is securing a connected world, delivering innovative solutions across the entire mobile ecosystem and beyond. The Company secures the world’s most sensitive data across all endpoints – from cars to smartphones – making the mobile-first enterprise vision a reality. Founded in 1984 and based in Waterloo, Ontario, the Company operates offices in North America, Europe, Middle East and Africa, Asia Pacific and Latin America. The Company’s common shares are listed on the NASDAQ Global Select Market (“NASDAQ”) (NASDAQ: BBRY) and the Toronto Stock Exchange (“TSX”) (TSX: BB), and its Debentures are listed on the TSX (TSX: BB.DB.U). The Mobile Communications Industry Improvements in wireless network infrastructure and the rapid proliferation of mobile devices and applications in recent years are transforming the way that enterprises and individuals communicate and collaborate. In the enterprise, the mobile platform is becoming the primary computing platform and users now ex...

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

CUSIP: 09228F903